AIHealthcare

Abridge is a privately held healthcare AI company that provides a generative AI platform for clinical conversations, functioning as an AI-native clinician intelligence layer for health systems, payers, and life sciences organizations. Its ambient “AI scribe” technology captures patient–clinician encounters and converts them into structured, billable clinical notes in real time, deeply integrated into electronic health record (EHR) workflows, with a focus on auditable, evidence-linked outputs for documentation, billing, decision support, and broader care coordination. Founded in 2018 out of the Pittsburgh Health Data Alliance, Abridge has rapidly become one of the most prominent and heavily funded companies in medical generative AI, working with 250–300+ health systems and aiming to serve as an operating system for medicine through partnerships with major health systems and strategic investors such as NVIDIA and Eli Lilly.